Source link : https://www.newshealth.biz/health-news/fast-acting-novel-depression-tx-lumryz-label-expanded-glp-1s-for-addiction/
As an adjunctive treatment to antidepressants, investigational SPN-820 — a novel, first-in-class intracellular modulator of mTORC1 that was developed to provide a rapid-onset response — was safe and effective in adults with major depressive disorder in a phase IIa study, said Supernus Pharmaceuticals. Risk of sudden cardiac death was 4.5-fold higher among patients with schizophrenic […]
Author : News Health
Publish date : 2024-10-23 17:49:24
Copyright for syndicated content belongs to the linked Source.
